// Dr Martens sales in the 12 months to March 31 jump 15% Y-o-Y to £773m
// Pre-tax profits took a heavy hit – down 30% to £70.9m – due to costs of £80.5m associated with IPO in January
// In the UK, trading was strong enough for Dr Martens to pay back £1.3m claimed from furlough scheme
Dr Martens has enjoyed soaring sales despite the Covid-19 pandemic leaving many people stuck indoors, although annual profits took a hit thanks to its stock market listing.
The footwear brand and retailer said sales in the 12 months to March 31 jumped 15 per cent year-on-year to £773 million, with strong growth in its online business.
However, pre-tax profits took a heavy hit – down 30 per cent to £70.9 million – due to costs of £80.5 million associated with Dr Martens’ stock market listing in January.
READ MORE:
- Dr Martens’ senior staff make millions after £3.7bn IPO
- Dr Martens unveils details of £3.7bn stock market float
The majority of the initial public offering (IPO) costs were due to a £49.1 million bonus paid out to staff.
Dr Martens did not give figures for each country in which it trades, but said sales in Europe rose 17 per cent, with the same levels of growth in North America and South America.
In the UK, the retailer shut down three stores, leaving 34 in total, but said trading was strong enough to be able to pay back £1.3 million claimed under the UK Government’s furlough scheme.
In the Asia-Pacific region sales grew just seven per cent due to slower growth in Japan, Dr Martens’ largest market in the area.
The retailer has a higher number of stores in Japan and they were closed due to the pandemic for large parts of the year.
Another major market in the region – China – saw revenues surge 46 per cent.
The majority of Dr Martens’ global growth came from online sales, where revenues from its website were up 73 per cent – meaning its ecommerce business now accounts for 30 per cent of all sales.
By comparison, sales in physical stores were down 40 per cent to £99.7 million.
The company’s wholesale business saw growth of 18 per cent to £437.9 million as it focused on having fewer relationships but with “quality partners”.
This saw strong growth from online-only retailers to which sell Dr Martens products and “robust trading” in the US.
with PA Wires
Click here to sign up to Retail Gazette‘s free daily email newsletter
